Literature DB >> 16322132

Infections and Kawasaki disease: implications for coronary artery outcome.

Susanne M Benseler1, Brian W McCrindle, Earl D Silverman, Pascal N Tyrrell, Joseph Wong, Rae S M Yeung.   

Abstract

OBJECTIVE: We sought to determine the effect of coincident infection, at time of diagnosis of Kawasaki disease (KD), on treatment response and coronary artery outcome.
METHODS: A single-center, retrospective study of 129 consecutive patients diagnosed with typical KD between January 1997 and December 1998 was performed. Standardized clinical assessments, laboratory, microbiology, and imaging test results plus treatment regimens were reviewed. Coronary arteries were visualized by using echocardiography, and coronary artery lesions (CALs) were reported as body surface area-adjusted z scores. Infection-positive and -negative groups were identified, and clinical, laboratory, and treatment data were analyzed. The effect of infections and other outcome variables on CAL development was determined by multivariate regression analysis.
RESULTS: (1) Concurrent infections: 33% of children with typical KD had > or =1 confirmed infection at KD diagnosis. (2) Treatment response: the presence of infection did not alter the response to treatment with intravenous immunoglobulin, with resolution of fever in 83% of children after 1 dose of intravenous immunoglobulin together with aspirin administration regardless of presence or absence of infection. (3) Coronary outcome: in total, 31% of the patients developed CALs. Both the proven-infection and no-proven-infection groups had a similar CAL frequency. (4) Multivariate regression analysis: proven infection did not increase the risk of coronary artery involvement even after adjusting for other factors impacting on coronary artery outcomes.
CONCLUSIONS: Infections are common at diagnosis of KD. A broad spectrum of infectious agents was found. Infections at diagnosis of KD did not affect the patients' response to treatment and coronary artery outcome when compared with those patients without infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322132     DOI: 10.1542/peds.2005-0559

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  45 in total

1.  Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report.

Authors:  Timothy Ronan Leahy; Eyal Cohen; Upton D Allen
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Familial Kawasaki disease and acute glomerulonephritis: case report and review of literature.

Authors:  Sarah A Salam Salih; Abdelbasit M A Elbashier; Nazik Abd Alaziz Alameen
Journal:  Sudan J Paediatr       Date:  2020

3.  A 21-year-old male with reduced left ventricular function.

Authors:  Klaus Hertting; Jacobus Reimers; Karl-Heinz Kuck
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

4.  A 13-Year-Old Boy Who Has Kawasaki Disease Shock Syndrome Presents with Parotitis.

Authors:  Yilmaz Yozgat; Selcuk Uzuner; Aysegul Dogan Demir; Mustafa Ogur; Can Yilmaz Yozgat; Ozden Turel
Journal:  J Pediatr Intensive Care       Date:  2019-10-09

5.  Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs.

Authors:  Murat Muhtar Yilmazer; Timur Mese; Savaş Demirpençe; Vedide Tavli; Ilker Devrim; Bariş Guven; Taliha Oner; Leman Tekin Orgun; Ayça Vitrinel
Journal:  Rheumatol Int       Date:  2009-08-19       Impact factor: 2.631

6.  Antibiotic use in children with Kawasaki disease.

Authors:  Seung Beom Han; Soo-Young Lee
Journal:  World J Pediatr       Date:  2018-04-30       Impact factor: 2.764

7.  Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis.

Authors:  Song Xiu-Yu; Huang Jia-Yu; Hong Qiang; Dai Shu-Hui
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

8.  Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.

Authors:  Fabienne Mueller; Walter Knirsch; Paul Harpes; René Prêtre; Emanuela Valsangiacomo Buechel; Oliver Kretschmar
Journal:  Clin Res Cardiol       Date:  2009-06-05       Impact factor: 5.460

9.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

10.  Associated symptoms in the ten days before diagnosis of Kawasaki disease.

Authors:  Annette L Baker; Minmin Lu; L LuAnn Minich; Andrew M Atz; Gloria L Klein; Rosalind Korsin; Linda Lambert; Jennifer S Li; Wilbert Mason; Elizabeth Radojewski; Victoria L Vetter; Jane W Newburger
Journal:  J Pediatr       Date:  2008-11-28       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.